Patient identification Platform Completes $2M Series A Funding

iplogoPatient identification Platform (Patient iP), a Victor, NY-based provider of clinical trial matching technology, completed a $2m Series A funding round.

The backers remained undisclosed.

The company intends to use the funds to accelerate its sales and marketing activities and expand its implementation team.

Founded in 2014 by Michael J. Margiotta, Patient iP enables contract research organizations (CROs) and/or life sciences companies, and their networked study sites, to access de-identified, aggregated patient data from existing electronic health records systems.
From here, discrete study protocols are loaded and applied against the database. Matched patients and their sites are identified based upon the inclusion and exclusion criteria of each protocol.
To date, the company has completed its platform development, launched a number of clinical trial study sites and recently received a letter of commitment from a large CRO.



Join the discussion